Finance

Lists
PHAR:NASDAQ
Pharming Group NV - ADR
$9.99
-0.20%
(-0.020) 1D
Sep 30, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PHAR...
Open
$10.16
High
$10.28
Low
$9.99
Mkt. cap
609.67M
Avg. vol.
30.73K
Volume
0.00
52-wk high
$21.30
52-wk low
$9.63
Beta
0.02
Shares outstanding
70.78M
No. of employees
407
Open
$10.16
High
$10.28
Low
$9.99
Mkt. cap
609.67M
Avg. vol.
30.73K
Volume
0.00
52-wk high
$21.30
52-wk low
$9.63
Beta
0.02
Shares outstanding
70.78M
No. of employees
407
News stories
From web sources and news partners
About Pharming Group NV - ADR
CEO-
Employees407
Founded1988
Headquarters-
SectorBiotechnology
Websitepharming.com
Analyst ratings
Based on 2 analysts giving stock ratings to PHAR in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for PHAR in the last 3 months.
Highest
Current $9.99
$38.00 (+280.38%)
Average
$37.50 (+275.38%)
Lowest
$37.00 (+270.37%)
Analyst
Recommendation
Action
Price target
Projected
Date
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$38.00
+280.4%
09/29/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
$37.00
+270.4%
09/30/2026
Jeff Jones
Oppenheimer
Buy
Maintained
$40.00
+300.4%
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
97.29M
106.53M
72.45M
90.21M
Cost of goods sold
7.07M
21.13M
6.64M
14.54M
Cost of revenue
7.07M
21.13M
6.64M
14.54M
Research and development expenses
21.28M
32.05M
25.56M
32.26M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
43.08M
50.67M
45.53M
43.52M
Operating expense
64.29M
82.37M
70.71M
74.36M
Total operating expenses
71.36M
103.50M
77.36M
88.90M
Operating income
25.92M
3.03M
-4.91M
1.31M
Other non operating income
1.88M
403.00K
-
-32.00K
EBT including unusual items
12.76M
4.80M
-4.75M
3.04M
EBT excluding unusual items
22.86M
1.61M
-4.75M
3.04M
Income tax expense
5.21M
-528.00K
459.00K
1.40M
Effective tax rate
40.83%
-11.00%
-9.65%
46.12%
Other operating expenses
-71.00K
-348.00K
-377.00K
-1.42M
Net income
7.55M
5.33M
-5.21M
1.64M
Net profit margin
7.76%
5.00%
-7.20%
1.82%
Earnings per share
0.01
0.01
-0.07
0.00
Interest and investment income
-
4.50M
3.24M
-
Interest expense
-9.21M
-
-2.70M
-4.10M
Net interest expenses
-9.21M
4.50M
542.00K
-4.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
30.12M
6.24M
-1.80M
2.67M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps